Accelerate to discover

Back to filter

Related topics

Rapid, Quantitative CEST Imaging with MRI Fingerprinting

Bruker Biospin

Apr 16, 2019

With applications spanning almost any disease area, from cancer, stroke, through to cardiac metabolism disorders, this...

Monitoring cancer treatments with immuno-PET webinar

Bruker Biospin

Mar 8, 2019

In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer...

Spectral data analysis webinar recording - Cytek flow cytometer and De Novo Software

Cytek Biosciences

Jan 17, 2019

Cytek Biosciences and De Novo Software are proud to announce a collaboration that allows you to work with your spectral...

IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy

Sartorius

Jan 11, 2019

The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...

Apr 20, 2019

Bioflux webinar: Blockade of CD62L inhibits CLL cell interaction with vascular endothelium

Fluxion Biosciences

Nov 22, 2018

CD62L (L-selectin) is a key adhesion molecule that promotes cell tethering and rolling along the vascular endothelium...

Xcell Bio webinar: AVATAR system, to control cell state to get better cells, fast

Xcell Biosciences

Oct 30, 2018

Dr. Schneider will show examples of data from customers who have incorporated pressure along with oxygen to recreate...

Webinar Tuning Microenvironment to Control Cells for Improved Disease Modeling & Immunotherapy Work

Xcell Biosciences

Jul 16, 2018

The company producing Avatar, xCELL biosciences have organized a webinar about the tuning of microenvironment to...

Apr 20, 2019

How microCT can provide insight into dynamic disease processes webinar

Bruker Biospin

Jun 19, 2018

Professor Vande Velde will describe how high-field MRI and low dose microCT complement each other; where microCT gives...

Show all topics (10)

Smart cell assays for immuno-oncology using IncuCyte ZOOM - Tuesday, June 28, 2016, 6 pm CEST

Jun 1, 2016

Tim O’Callaghan, Essen BioScience.

For the body to defend and fight against cancer, immune cells must recognize, engage, destroy and ultimately remove unwanted tumor cells. Understanding these processes at the cellular level is central to identifying and validating new immunotherapy approaches. Current methods for studying immune/tumor cell interactions are often end point, require cell lifting or measure indirect readouts meaning valuable data may be overlooked or compromised. In this webinar you will learn how continuous live-cell analysis enables a new range of non-invasive phenotypic measurements for immuno-oncology research including:

-Immune cell activation, chemotaxis and transendothelial migration
-Tumor cell proliferation and metastatic potential
-Immune cell killing of tumor cells and clearance by phagocytosis

These real-time, live-cell assays provide deeper biological insight into the full time course of events. Direct, image-based analyses offer valuable morphological information and ensure every measurement can be validated with images and movies. Fully automated image capture and analysis enhance workflow productivity. A series of case studies will be shared to illustrate these advantages and how researchers are using live-cell analysis to drive their immuno-oncology discovery.

Register now

Webinar

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

Sartorius

Essen BioScience (part of Sartorius), is a team of engineers and biologists with deep expertise in cell-based assays. We invent, manufacture, supply and support cell-based assay instrumentation, reagents and protocols.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey